AMYLIN PHARMACEUTICALS INC Interest Expense
AMYLIN PHARMACEUTICALS INC reported Interest Expense of $2.85 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC interest expense for the quarter ending 2012-06-30 was $2.85M, a 185.09% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC interest expense for the quarter ending 2011-06-30 was $999.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month |
|---|---|---|
| 2012-06-30 | $2.85M 10-Q · filed 2012-08-03 | $5.70M 10-Q · filed 2012-08-03 |
| 2011-06-30 | $999.00K 10-Q · filed 2012-08-03 | $1.02M 10-Q · filed 2012-08-03 |